Reference page — cumulative record through Monday, October 19, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
InvoicePlane
Product reference — InvoicePlane by Invoiceplane · sector: Other. Cumulative disclosure record for this product across the archive.
Follow InvoicePlane — Atom feed
Product totals
| All-time | YTD | |
|---|---|---|
| CVEs | 15 | 15 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 6.5 | .0026 | 1 | 6 | 8 | 0 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Monthly disclosures
Trend (by first-seen month, full archive): █▁
| Month | New CVEs |
|---|---|
| 2026-09 | 15 |
| 2026-10 | 0 |
Notable CVEs
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-50547 | 7.5 | 38.8 | HIGH | — | 2026-09-25 |
| CVE-2026-39353 | 9.1 | 37.5 | CRITICAL | — | 2026-09-25 |
| CVE-2026-33639 | 7.2 | 32.6 | HIGH | — | 2026-09-25 |
| CVE-2026-49850 | 7.5 | 24.0 | HIGH | — | 2026-09-25 |
| CVE-2026-88003 | 7.5 | 21.0 | HIGH | — | 2026-09-25 |
| CVE-2026-39372 | 4.9 | 19.0 | MEDIUM | — | 2026-09-25 |
| CVE-2026-100371 | 8.7 | 18.7 | HIGH | — | 2026-09-28 |
| CVE-2026-85291 | 6.5 | 16.0 | MEDIUM | — | 2026-09-25 |
| CVE-2026-85292 | 4.8 | 15.7 | MEDIUM | — | 2026-09-25 |
| CVE-2026-85290 | 5.3 | 14.0 | MEDIUM | — | 2026-09-25 |
| CVE-2026-54790 | 6.0 | 13.1 | MEDIUM | — | 2026-09-25 |
| CVE-2026-100392 | 7.0 | 12.7 | HIGH | — | 2026-09-28 |
| CVE-2026-85293 | 4.8 | 12.2 | MEDIUM | — | 2026-09-25 |
| CVE-2026-85274 | 6.5 | 5.7 | MEDIUM | — | 2026-09-25 |
| CVE-2026-85289 | 6.5 | 5.7 | MEDIUM | — | 2026-09-25 |
Recent CVEs
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-100371 | 8.7 | 18.7 | HIGH | — | 2026-09-28 |
| CVE-2026-100392 | 7.0 | 12.7 | HIGH | — | 2026-09-28 |
| CVE-2026-85290 | 5.3 | 14.0 | MEDIUM | — | 2026-09-25 |
| CVE-2026-39372 | 4.9 | 19.0 | MEDIUM | — | 2026-09-25 |
| CVE-2026-33639 | 7.2 | 32.6 | HIGH | — | 2026-09-25 |
| CVE-2026-88003 | 7.5 | 21.0 | HIGH | — | 2026-09-25 |
| CVE-2026-85291 | 6.5 | 16.0 | MEDIUM | — | 2026-09-25 |
| CVE-2026-54790 | 6.0 | 13.1 | MEDIUM | — | 2026-09-25 |
| CVE-2026-85289 | 6.5 | 5.7 | MEDIUM | — | 2026-09-25 |
| CVE-2026-85293 | 4.8 | 12.2 | MEDIUM | — | 2026-09-25 |
| CVE-2026-85292 | 4.8 | 15.7 | MEDIUM | — | 2026-09-25 |
| CVE-2026-50547 | 7.5 | 38.8 | HIGH | — | 2026-09-25 |
| CVE-2026-49850 | 7.5 | 24.0 | HIGH | — | 2026-09-25 |
| CVE-2026-39353 | 9.1 | 37.5 | CRITICAL | — | 2026-09-25 |
| CVE-2026-85274 | 6.5 | 5.7 | MEDIUM | — | 2026-09-25 |
KEV entries
No entries in the CISA KEV catalog.
Related
Vendor: Invoiceplane — all products and the full vendor record.
Methodology
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.
